Latest Breaking News On - Research development at annovis bio - Page 1 : vimarsana.com

/PRNewswire/ Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,.

United statesMarial maccecchiniNic johnsonCheng fangAnnovis bioExchange commissionPrnewswire annovis bio incCompany phaseResearch development at annovis bioDrug administrationAnnovis bio incRusso partnersNovel translational inhibitorMultiple neurotoxic proteinsBoth alzheimerSenior vice president